Retina Associates of Cleveland, Inc. : Research/Clinical Trials

"...Quality retinal care you can trust"

home | site map

216-831-5700 / 800-622-8521

PHYSICIANS

YOUR VISIT

RESEARCH/CLINICAL TRIALS

PATIENT EDUCATION

LOW VISION SERVICES

NEWS & LINKS

PROFESSIONAL RESOURCES

CONSULT REQUEST

Select display options below. (Cookies need to be enabled in your browser!)
Colors: High contrast Default Font Size: X-Large Large Medium Default Small

Clinical Trials and Research
We feel strongly about participation in clinical research and are dedicated to exploring newer and better treatment options for our patients. Our physicians and nurses are available to discuss participation in clinical trials and whether it is right for you.
Diane W., RN, BSN
Diane graduated from BGSU, working 7 yrs in Med/Surg and Home Care, then 15 yrs at Mt. Sinai as a Clinical Specialist/Practice Manager of the Eye Clinic and coordinator for the Ophthalmology Residency program. Diane joined RACI in 1999 and serves as the Sr. Clinical Nurse and Study Coordinator.
Kimberly D., LPN, CCRP
Kimberly has worked in ophthalmology since 1984, and started at Retina Associates of Cleveland in 1994. While at Retina Associates she has worked as a Technician assisting the physicians, coordinated multiple clinical trials and manages the Low Vision Resource Center, located in the Beachwood office.
Dianne H., RN, BSN, CCRC
Dianne has been an RN since 1984. She started clinical research with the Cleveland Clinic in 1997, and in 1991 received her certification as a Clinical Research Nurse. Dianne joined Retina Associates of Cleveland in 2006. She has personally coordinated over 50 clinical trials.
Lori R., COA
Lori is a Certified Ophthalmic Assistant and has worked for RACI since 1990. She is a Photographer/Technician who has worked with several clinical trials over the years as both a Clinic Coordinator and Study Photographer.
Larraine (Rae) S., RN, BA, CCRC
Larraine (Rae) S., RN, BA, CCRC has been an RN since 1984 and a Clinical Research Nurse since 1988. Rae also holds a BBA from Baldwin Wallace. She was employed by UH for 17 years with experience in multiple disciplines and the Cleveland Clinic for 5 years. Rae joined RACI in 2007 and is certified as a Clinical Research Coordinator.
Susan R., PA-C
Susan has been working at RACI since 1988. She has worked in the office, operating room, and in clinical research, and for the last 10 years has had a main focus in Clinical Drug Research. Susan said that the most gratifying aspect of clinical drug research is participating in a study in which the drug proves to be beneficial for patients and obtains FDA approval.
Tammy B., MA/COA
Tammy has been with Retina Associates of Cleveland since 2001 as clinical technician/study refractor/study coordinator. She worked in general ophthalmology for 10 years prior to joining RACI.
Trina N., COT
Trina has been working in Ophthalmology since 1991. She has been employed with Retina Associates of Cleveland since 2003. Her background in Ophthalmology includes working as a Technician, a Clinical Research Coordinator and as a Study Photographer. Trina likes to be active in local and national ophthalmology organizations.
Vivian T., CCRP, COT
Vivian has been a Certified Clinical Research Professional since 2003. In addition, she has experience in multiple disciplines: 33 years experience as a Certified Ophthalmic Technician, 25 years experience as a Clinical Research Coordinator, 18 years experience as an Ultra-sonographer and 25 years as an Electroretinographer. Vivian has been with Retina Associates of Cleveland since 1993.

Quick Links

Select a link below for details.

Age-related Macular Degeneration

Diabetic Retinopathy

Retinal Vein Occlusion

Other Diagnoses

Research & Clinical Trials

Study Detail: DRCR N

Trial Description Summary The study is being conducted to determine if intravitreal injections of ranibizumab decrease the proportion of eyes in which vitrectomy is performed compared with saline injections in eyes presenting with vitreous hemorrhage from proliferative diabetic retinopathy.

Basic Trial Information

Disease under study: Vitreous hemorrhage due to PDR

Age: 18 or older

Sponsor: National Institue of Health (NIH)

Protocol #: DRCR

Study Duration: 52 weeks

OPHTHALMIC INCLUSION
*Vitreal hemorrhage causing vision impairment, presumed to be from PDR and precluding completion of PRP (or precluding assessment of completeness of prior PRP) A prior full session of PRP is permitted provided that the *VH precludes assessment of the completeness of the prior treatment on clinical exam.
*Immediate vitrectomy not required for at least 8 weeks
*Visual acuity is light perception or better
*Other inclusion criteria per protocol
GENERAL OPHTHALMIC EXCLUSION
*Need for immediate vitrectomy due to Rhegmatogenous RD or traction detachment involving the macula present on ultrasound
*Exam evidence of NVG, Angle NV or active NVI (small iris tufts not an exclusion)
*History of intravitreal anti-VEGF TX for VH at any time in the past or for an indication other than VH in the past 2 months
*History of vitrectomy
*Other exclusion criteria per protocol
GENERAL MEDICAL EXCLUSION
*MI, stroke, TIA, cardiac event requiring hospitalization, or acute CHF within 4months prior to randomization.
*Other criteria per protocol

Study Title
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy

Trial Contact Information
Site Study Coordinator
Beachwood 216/831-5700 x 253
Middleburg Hts. 216/831-5704 x 253

Clinical Trials and Research

Diane W., RN, BSN

Kimberly D., LPN, CCRP

Dianne H., RN, BSN, CCRC

Lori R., COA

Larraine (Rae) S., RN, BA, CCRC

Susan R., PA-C

Tammy B., MA/COA

Trina N., COT

Vivian T., CCRP, COT